Glucocorticoid treatment reduces exhaled nitric oxide in cystic fibrosis patients Source: Eur Respir J 2001; 17: 1267-1270 Year: 2001
Effect of inhaled L-arginine on airway nitric oxide in cystic fibrosis patients Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle Year: 2005
Airway nitric oxide production in patients with cystic fibrosis increases with ivacaftor therapy Source: International Congress 2015 – Cystic fibrosis: assessment and treatment Year: 2015
Oral N-acetylcysteine attenuates the rat pulmonary inflammatory response to antigen Source: Eur Respir J 2003; 21: 394-400 Year: 2003
Antibiotic treatment decreases exhaled nitric oxide levels in cystic fibrosis patients Source: Eur Respir J 2004; 24: Suppl. 48, 384s Year: 2004
Elevated levels of alveolar nitric oxide in patients with inflammatory bowel disease Source: International Congress 2016 – Airway biomarkers Year: 2016
Increased nitric oxide synthase isoforms, endothelin 1 and apoptosis varied in lungs from patients with (SSc) and had impact on pulmonary function tests Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010
Oral L-arginine supplementation in cystic fibrosis patients: a placebo-controlled study Source: Eur Respir J 2005; 25: 62-68 Year: 2005
Exhaled nitric oxide in stable adult cystic fibrosis patients, during exacerbation and following CFTR-modifying treatment Source: Eur Respir J, 53 (5) 1802259; 10.1183/13993003.02259-2018 Year: 2019
Effects of chronic nitric oxide inhibition on eosinophil recruitment and extracellular matrix remodelling in chronic pulmonary inflammation Source: Eur Respir J 2007; 30: Suppl. 51, 735s Year: 2007
Increased eNO and pulmonary iNOS expression in eNOS null mice Source: Eur Respir J 2003; 21: 770-773 Year: 2003
Effects of oral tolerance on neuronal nitric oxidase synthase expression on bronchial epithelial cells in a model of chronic pulmonary inflammation Source: Annual Congress 2007 - Mouse models of allergic airway inflammation Year: 2007
Effects of nitric oxide synthase up-regulation in early remodeling of usual interstitial pneumonia has impact on long term outcome of patients Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis? Year: 2011
Prognostic evaluation of alveolar concentration of nitric oxide, serum periostin and CD59 in patients with idiopathic pulmonary fibrosis Source: International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia Year: 2019
Increased exhaled nitric oxide precedes lung fibrosis in a murine model of systemic sclerosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease Year: 2012
Influence of inhaled nitric oxide on plasma endothelin-1 in pulmonary hypertension Source: Eur Respir J 2003; 22: Suppl. 45, 463s Year: 2003
Nitric oxide modulates vascular remodelling in a model of chronic allergic lung inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 432s Year: 2006
Effect of the Asp298 variant of endothelial nitric oxide synthase on acute pulmonary vasodilator testing response in idiopathic pulmonary arterial hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 547s Year: 2006
Long-term effect of CFTR modulator therapy on airway nitric oxide Source: Eur Respir J, 55 (1) 1901113; 10.1183/13993003.01113-2019 Year: 2020
Inducible nitric oxide synthase inhibition modulates lung tissue extracellular matrix remodelling induced by chronic allergic inflammation Source: Annual Congress 2007 - New treatments for asthma and COPD - experimental evidence Year: 2007